Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Colorectal Carcinoma
|
1186 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.090 | 0.778 | 9 | 2010 | 2019 | |||||
Malignant Neoplasms
|
1441 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.050 | 1.000 | 5 | 2008 | 2019 | |||||
Carcinoma of lung
|
995 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.040 | 1.000 | 4 | 2011 | 2017 | |||||
Malignant neoplasm of lung
|
1000 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.040 | 1.000 | 4 | 2011 | 2017 | |||||
Primary malignant neoplasm
|
1374 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.040 | 1.000 | 4 | 2008 | 2019 | |||||
Primary malignant neoplasm of lung
|
981 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.040 | 1.000 | 4 | 2011 | 2017 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||
Malignant neoplasm of stomach
|
603 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.020 | 1.000 | 2 | 2016 | 2017 | |||||
Neoplasms
|
1571 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.020 | 1.000 | 2 | 2015 | 2019 | |||||
Stomach Carcinoma
|
616 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.020 | 1.000 | 2 | 2016 | 2017 | |||||
Adult Glioblastoma
|
98 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Carcinoma, Ovarian Epithelial
|
321 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Childhood Glioblastoma
|
98 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Colon Carcinoma
|
275 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.010 | 1 | 2017 | 2017 | ||||||
Dyssegmental dysplasia, Rolland-Desbuquois type
|
1 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Glioblastoma
|
157 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Glioblastoma Multiforme
|
160 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Liver carcinoma
|
769 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Male infertility
|
137 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Malignant neoplasm of ovary
|
246 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Malignant neoplasm of stomach stage IV
|
7 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Malignant tumor of colon
|
289 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.010 | 1 | 2017 | 2017 | ||||||
Marinesco-Sjogren syndrome
|
7 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Neoplasm Metastasis
|
327 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Oligospermia
|
71 | 0.653 | 0.400 | 3 | 36993455 | 5 prime UTR variant | G/A | snv | 0.22 | 0.010 | 1.000 | 1 | 2019 | 2019 |